|
SNX24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.048400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.730000E-01 |
| Normal-vs-Stage2 |
8.009400E-01 |
| Normal-vs-Stage3 |
8.319600E-01 |
| Normal-vs-Stage4 |
9.968600E-01 |
| Stage1-vs-Stage2 |
4.084600E-01 |
| Stage1-vs-Stage3 |
8.138600E-01 |
| Stage1-vs-Stage4 |
7.878200E-01 |
| Stage2-vs-Stage3 |
7.109600E-01 |
| Stage2-vs-Stage4 |
9.111200E-01 |
| Stage3-vs-Stage4 |
9.075000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.790100E-02 |
| Normal-vs-AfricanAmerican |
2.467000E-01 |
| Normal-vs-Asian |
4.017200E-01 |
| Caucasian-vs-AfricanAmerican |
1.725520E-02 |
| Caucasian-vs-Asian |
3.060400E-01 |
| AfricanAmerican-vs-Asian |
5.294600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.666960E-01 |
| Normal-vs-Female |
6.165200E-01 |
| Male-vs-Female |
1.330180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.293600E-01 |
| Normal-vs-Extreme_Weight |
3.017000E-01 |
| Normal-vs-Obese |
4.592200E-01 |
| Normal-vs-Extreme_Obese |
5.997400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.634400E-01 |
| Normal_Weight-vs-Obese |
9.055400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.075200E-01 |
| Extreme_Weight-vs-Obese |
9.167400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.280000E-01 |
| Obese-vs-Extreme_Obese |
3.138400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.473000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.968200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.590800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.032600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.380200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.615000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.957200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.770200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.988000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.145200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.127010E-01 |
| Normal-VS-Type2 PRCC |
3.467200E-01 |
| Normal-VS-KIRP CIMP |
4.306200E-02 |
| Normal-VS-Unclassified PRCC |
9.386600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.761660E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.855200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.511200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.553550E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.212800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.735810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.996400E-01 |
| Normal-vs-N1 |
8.142200E-01 |
| Normal-vs-N2 |
1.375620E-01 |
| N0-vs-N1 |
4.420800E-01 |
| N0-vs-N2 |
6.230000E-01 |
| N1-vs-N2 |
3.572600E-01 |
|
|
